Drinking 1 cup of caffeinated coffee a day might help lower a person's risk of recurrent AFib episodes by as much as 39%, a ...
A common chemical used in dry cleaning and for certain consumer products called tetrachloroethylene (PCE) may triple a person ...
Some bacterial species, particularly some linked to inflammation, are associated with coronary artery disease, a common form ...
Three medical experts review the evidence around how antidepressants may affect the gut microbiome, and what this could mean ...
Vitamin D3 may help drastically reduced the risk of having a second heart attack, a new clinical trial has found.
Scientists have found that they may be able to use the retina's blood vessels to help predict a person's heart disease risk ...
Researchers from the University of Birmingham have found that flavanols, which are found in cocoa, tea, and berries, may help ...
Heartburn is a common symptom of acid reflux, occurring when stomach contents flow back into the esophagus. Frequent occurrences may indicate gastroesophageal reflux disease (GERD). Lifestyle ...
Although the link between raised risk of dementia and anticholinergics has been found before, the new study uses more rigorous methods – including over 7 years of follow-up – to establish the strength ...
For the first time, scientists have managed to restore central vision loss from an irreversible age-related eye condition via ...
Semaglutide, the active ingredient in Wegovy and Ozempic, lowers major cardiac event risk, regardless of how much weight a person loses while taking the GLP-1 medication, a new study finds.
Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early Alzheimer's disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results